Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksBLISSGVS
resources
BLISSGVS

Bliss GVS Pharma Ltd.

NSE: BLISSGVS
BSE: 506197
Sector: Healthcare
Industry: Pharmaceuticals
660.70-14.3 (-2.12%)
14 Oct, 12:00 AM

Annual Reports and Financial Documents

Bliss GVS Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Bliss GVS Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General14 Oct 2026
    Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
    Please find enclosed herewith the disclosure under Regulation 31A (10) of the SEBI Regulations in relation to re-classification from the "promoter and promoter Group category" to the "public" category
  2. Newspaper Publication14 Oct 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the newspaper advertisement published regarding the Extension of Special Window for Re-Lodgement of Transfer Requests of Physical Shares.
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended September 30, 2026.
  4. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20116 Oct 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
  5. Outcome of Board Meeting1 Oct 2026
    Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")
    Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday, October 01, 2026 through Video Conferencing or Other Audio Visual Means.
  6. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20111 Oct 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anupam Rasayan India Ltd
  7. Closure of Trading Window29 Sept 2026
    Closure of Trading Window
    Please find enclosed herewith the Intimation for the Closure of the Trading Window w.e.f. Thursday, October 01, 2026.
  8. Board Meeting28 Sept 2026
    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, October 01, 2026
    Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2026 ,inter alia, to consider and approve Please find enclosed herewith ....
  9. Meeting Updates28 Sept 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    Please find enclosed herewith the Outcome of the 2nd Board Meeting held on September 28, 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category ....
  10. Meeting Updates28 Sept 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    Please find enclosed herewith the Outcome of the 1st Board Meeting held on September 28, 2026 at shorter Notice pursuant to the consummation of the transaction contemplated in the share ....
  11. Change in Management Control28 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management Control
    Please find enclosed herewith the Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company.
  12. Postal Ballot22 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Please find enclosed herewith the outcome of the Postal Ballot along with the Scrutinizer''s Report and Voting Results.
  13. Postal Ballot22 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Please find enclosed herewith the Disclosure of Voting Results of the Postal Ballot along with the Scrutinizer''s Report.
  14. Allotment of ESOP / ESPS4 Sept 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    We would like to inform you that the ESOP Allotment Committee of the Company at its meeting held on today i.e. September 04, 2026 has approved the allotment of 55,250 equity shares of ....
  15. General2 Sept 2026
    Post-Offer Advertisement
    SBI Capital Markets Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post-Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of ....
  16. Newspaper Publication25 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the Newspaper Publication regarding the extension of the Special Window for Re-Lodgement of Transfer Request of Physical Shares.
  17. Newspaper Publication21 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the Newspaper Publication regarding the publication of the advertisement for the Postal Ballot Notice.
  18. Postal Ballot20 Aug 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Please find enclosed herewith the Postal Ballot Notice ("Notice") dated August 12, 2026, alongwith the Explanatory Statement for seeking approval of Members of the Company by way of remote ....
  19. Newspaper Publication14 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the copies of newspaper advertisement published regarding the extract of statement of Un-audited Standalone and Consolidated Financial Results of the Company ....
  20. General12 Aug 2026
    Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019
    Please find enclosed herewith the outcome of Members of the Nomination and Remuneration Committee of Bliss GVS Pharma Limited ("the Company")in its meeting held today i.e. on August 12, ....

Frequently Asked Questions

Where can I download the annual report of Bliss GVS Pharma Ltd.?
Annual reports of Bliss GVS Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Bliss GVS Pharma Ltd.?
Quarterly earnings results and presentations of Bliss GVS Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Bliss GVS Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Bliss GVS Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Bliss GVS Pharma Ltd.?
Investor presentations and annual day presentations of Bliss GVS Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Bliss GVS Pharma Ltd.?
Corporate announcements and regulatory filings of Bliss GVS Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Bliss GVS Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Bliss GVS Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Bliss GVS Pharma Ltd.?
The ISIN (International Securities Identification Number) of Bliss GVS Pharma Ltd. is INE416D01022. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Bliss GVS Pharma Ltd. listed?
Bliss GVS Pharma Ltd. is listed on NSE and BSE. The NSE symbol is BLISSGVS and the BSE code is -.
Where can I find the shareholding pattern of Bliss GVS Pharma Ltd.?
The quarterly shareholding pattern of Bliss GVS Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Bliss GVS Pharma Ltd. on Sharpely?
Share price data for Bliss GVS Pharma Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.